J. Chediak

发表

Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets.

M. Ginsberg, E. Plow, M. Ginsberg, 1983, The Journal of clinical investigation.

Pulmonary function in hemophiliac patients treated with commercial factor VIII concentrates.

M. Telfer, J. Chediak, A. Chausow, 1984, The American journal of medicine.

Red blood cell effect on platelet adhesion and aggregation in low-stress shear flow. Myth or fact?

R. Beissinger, T. Alkhamis, J. Chediak, 1988, ASAIO transactions.

von Willebrand's disease and pregnancy: management during delivery and outcome of offspring.

J. Chediak, G. Alban, B. Maxey, 1986, American journal of obstetrics and gynecology.

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study.

P. Mannucci, C. Kessler, B. Ewenstein, 2002, Blood.

Antithrombin "Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia.

K. Bauer, R. Rosenberg, J. Chediak, 1983, Blood.

Successful management of bleeding in a patient with factor V inhibitor by platelet transfusions.

R. Desser, J. Chediak, J. Ashenhurst, 1980, Blood.

Pathologic Quiz Case A 29-Year-Old Woman With Thrombocytosis

E. Weisenberg, J. Chediak, Horea Baila, 2009 .

von Willebrand's disease: current concepts.

D. Green, J. Chediak, 1977, The American journal of medicine.

Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion.

M. Telfer, D. Green, J. Chediak, 1977, The American journal of medicine.

ABSENCE OF RISTOCETIN AGGREGATION FACTOR FROM THE SKIN OF A PATIENT WITH VON WILLEBRAND'S DISEASE

D. Green, J. Chediak, E. Potter, 1976, The Lancet.

Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype.

P. Mannucci, R. Ljung, C. Kasper, 1986, Blood.

Human Plasminogen Variant Chicago III

K. Robbins, L. Summaria, R. Wohl, 1982, Thrombosis and Haemostasis.

Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostate

O. Ratnoff, G. Goldsmith, J. Chediak, 1986, British journal of haematology.

Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII

H. Liebman, A. Galvez, J. Chediak, 2000, American journal of hematology.

Determination of factor VIII-related antigen using commercial antisera.

M. Telfer, J. Chediak, B. Maxey, 1977, American journal of clinical pathology.

Cycles of Agglutination‐Disagglutination Induced by Ristocetin in Thrombasthenic Platelets

M. Telfer, J. Chediak, I. Cohen, 1979, British journal of haematology.

Characterization and properties of cultured human von Willebrand umbilical vein endothelial cells.

T. Maciag, M. Stemerman, F. Booyse, 1981, Blood.

Antithrombotic agents in coronary artery disease.

J. Cairns, J. Hirsh, P. Théroux, 1989, Chest.

Lower factor VIII coagulant in daughters of subjects with hemophilia A compared to other obligate carriers.

M. Telfer, D. Green, J. Chediak, 1980, Blood.

Carrier detection in hemophilia A: a cooperative international study. II. The efficacy of a universal discriminant.

P. Mannucci, R. Ljung, C. Kasper, 1986, Blood.

Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.

D. Livingston, D. Lynch, J. Chediak, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Effect of hirudin on platelet deposition to an artificial surface during low-stress shear flow of whole blood.

R. Beissinger, T. Alkhamis, J. Chediak, 1993, Biomaterials.

Correction of clot retraction in thrombasthenia by ATP and ristocetin.

J. Chediak, B. Maxey, E. Lambert, 1978, Thrombosis research.

Artificial surface effect on red blood cells and platelets in laminar shear flow.

R. Beissinger, T. Alkhamis, J. Chediak, 1990, Blood.

Quantitative and qualitative platelet abnormalities during pregnancy

M. Koshy, F. Bergmann, J. Chediak, 1991, American journal of obstetrics and gynecology.

Warfarin‐induced limb gangrene in the setting of lung adenocarcinoma

L. Klein, O. Klein, A. Galvez, 2004, American journal of hematology.

Combined severe factor XI deficiency and von Willebrand's disease.

M. Telfer, J. Chediak, E. Johnson, 1980, American journal of clinical pathology.

Lower Factor VIII Coagulant Activity in Daughters of Subjects With Hemophilia A Compared to Other Obligate Carriers

M. Telfer, D. Green, J. Chediak, 2005 .

The Role of von Willebrand Factor in Pre-Eclampsia

S. Rotmensch, F. Bergmann, J. Chediak, 1991, Thrombosis and Haemostasis.

Diffuse alveolar hemorrhage secondary to superwarfarin ingestion.

F. Bergmann, J. Chediak, V. Barnett, 1992, Chest.

efficacy of a universal discriminant Carrier detection in hemophilia A: a cooperative international study. II. The

R. Ljung, E. Briet, J. Chediak, 2011 .

Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregation.

R. Entwistle, B. Anderson, J. Chediak, 1981, The Journal of laboratory and clinical medicine.

M. Telfer, J. Chediak, 1977, The Journal of reproductive medicine.

Surgical implications of antithrombin III deficiency.

R. Karl, J. Chediak, I. Garlick, 1981, Surgery.